Skip to main content
OpenTrials

Clinical trial condition

Thrombocytopenia

Explore clinical trials studying Thrombocytopenia. Study availability and eligibility vary by location and protocol.

403 public trials 115 recruiting studies
Refine in advanced search Browse all conditions

Thrombocytopenia trial results

Recruiting

A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)

NCT07421167

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +18 more
Locations
  • Stamford Hospital Stamford, Connecticut, United States
  • Baptist MD Anderson Cancer Center Jacksonville, Florida, United States
  • DH Cancer Research Center LLC Margate, Florida, United States
  • Hope And Healing Care Hinsdale, Illinois, United States
View Trial Details
Recruiting

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

NCT06948318

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • USC Norris Comprehensive Cancer Center - Keck Medicine of USC Los Angeles, California, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • Georgetown University Medical Center - Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States
  • Emory University Atlanta, Georgia, United States
View all 109 locations
View Trial Details
Recruiting

A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)

NCT07194850

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +22 more
Locations
  • Centre Hospitalier Universitaire de Bordeaux Groupe Hospitalier Pellegrin Hopital des Enfants Bordeaux, France
  • Charite - Universitaetsmedizin Berlin - Campus Virchow-Klinikum (CVK) Berlin, Germany
  • Gaslini Children's Hospital Genoa, Italy
  • Fondazione IRCCS San Gerardo dei Tintori Monza, Italy
View all 20 locations
View Trial Details
Recruiting

A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

NCT06533098

Conditions
Blood Platelet Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cytopenia, +5 more
Locations
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • UC Davis School of Medicine Sacramento, California, United States
  • Childrens Hospital Colorado Aurora, Colorado, United States
  • Advocate Children's Hospital Park Ridge, Illinois, United States
View all 26 locations
View Trial Details
Recruiting

A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia

NCT06721013

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Stanford University Stanford, California, United States
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • University of Miami Hospital and Clinics Sylvester Comprehensive Cancer Center Miami, Florida, United States
View all 45 locations
View Trial Details
Recruiting

Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment

NCT07007962

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Community Health Partners (CHP) - Community Medical Oncology Specialists (University Oncology Associates) Clovis, California, United States
  • University of Southern California (USC) Los Angeles, California, United States
  • Tulane University Health Sciences Center - Tulane Avenue-Investigational Site Number: 8400011 New Orleans, Louisiana, United States
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
View all 36 locations
View Trial Details
Recruiting

TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients

NCT04098445

Conditions
Blood Platelet Disorders, Bronchial Diseases, Bronchiolitis, +14 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Dana-Farber Cancer Institute/Boston Children's Hospital Boston, Massachusetts, United States
  • University of Minnesota Minneapolis, Minnesota, United States
View Trial Details

Related conditions